Clinical Trial

Muscle Dysfunction in Patients With Haematological Diseases

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
PURPOSE: To evaluate the prevalence and prognostic value of sarcopenia in patients diagnosed with hematological cancer diseases.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2025-10-30 -> 2026-10-30 2026-08-15
minor Completion pushed: 2026-05-01 -> 2026-12-01 2026-08-15
Trial Details
NCT Number NCT05150561
Lead Sponsor Rigshospitalet, Denmark
Conditions Hematologic Diseases, Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Myelodysplastic Syndromes, Lymphoma
Enrollment 216 participants
Start Date 2023-10-01
Primary Completion 2026-10-30 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-14